Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G. Patti G, et al. Am J Cardiol. 2011 Apr 1;107(7):995-1000. doi: 10.1016/j.amjcard.2010.11.025. Epub 2011 Jan 20. Am J Cardiol. 2011. PMID: 21256470
Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
Patti G, Pasceri V, D'Antonio L, D'Ambrosio A, Macrì M, Dicuonzo G, Colonna G, Montinaro A, Di Sciascio G. Patti G, et al. Am J Cardiol. 2012 Aug 15;110(4):478-84. doi: 10.1016/j.amjcard.2012.04.017. Epub 2012 May 12. Am J Cardiol. 2012. PMID: 22583760 Clinical Trial.
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study.
Mangiacapra F, Patti G, Barbato E, Orlic D, Peace AJ, D'Ambrosio A, Ostojic M, Wijns W, Di Sciascio G. Mangiacapra F, et al. Among authors: patti g. Int J Cardiol. 2012 Oct 18;160(3):213-4. doi: 10.1016/j.ijcard.2012.06.015. Epub 2012 Jun 22. Int J Cardiol. 2012. PMID: 22727961 Clinical Trial. No abstract available.
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
Patti G, Mangiacapra F, Ricottini E, Cannatà A, Cavallari I, Vizzi V, D'Ambrosio A, Dicuonzo G, Di Sciascio G. Patti G, et al. Am J Cardiol. 2013 Jun 15;111(12):1739-44. doi: 10.1016/j.amjcard.2013.02.028. Epub 2013 Mar 26. Am J Cardiol. 2013. PMID: 23538022
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.
Patti G, De Caterina R, Abbate R, Andreotti F, Biasucci LM, Calabrò P, Cioni G, Davì G, Di Sciascio G, Golia E, Golino P, Malatesta G, Mangiacapra F, Marcucci R, Nusca A, Parato VM, Pengo V, Prisco D, Pulcinelli F, Renda G, Ricottini E, Ruggieri B, Santilli F, Sofi F, Zimarino M; Working Group on Thrombosis of the Italian Society of Cardiology. Patti G, et al. Eur Heart J. 2014 Sep 1;35(33):2213-23b. doi: 10.1093/eurheartj/ehu279. Epub 2014 Jul 14. Eur Heart J. 2014. PMID: 25024407 Review.
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.
Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, Freynhofer MK, ten Berg J, Janssen P, Angiolillo DJ, Siller-Matula JM, Marcucci R, Patti G, Mangiacapra F, Valgimigli M, Morel O, Palmerini T, Price MJ, Cuisset T, Kastrati A, Stone GW, Sibbing D. Aradi D, et al. Among authors: patti g. Eur Heart J. 2015 Jul 14;36(27):1762-71. doi: 10.1093/eurheartj/ehv104. Epub 2015 Apr 20. Eur Heart J. 2015. PMID: 25896078 Review.
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study).
Ricottini E, Madonna R, Grieco D, Zoccoli A, Stampachiacchiere B, Patti G, Tonini G, De Caterina R, Di Sciascio G. Ricottini E, et al. Among authors: patti g. Am J Cardiol. 2016 Jan 15;117(2):165-71. doi: 10.1016/j.amjcard.2015.10.043. Epub 2015 Nov 6. Am J Cardiol. 2016. PMID: 26743348 Clinical Trial.
587 results